NYSE:BBLN Babylon Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Babylon Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. $1.08 -0.08 (-6.90%) (As of 06/24/2022 12:00 AM ET) Add Compare Share Today's Range$1.05▼$1.1650-Day Range$0.96▼$3.7252-Week Range$0.95▼$16.00Volume10.65 million shsAverage Volume745,755 shsMarket Capitalization$46.58 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BBLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Babylon and its competitors with MarketBeat's FREE daily newsletter. Email Address BBLN Stock Forecast (MarketRank)Overall MarketRank™1.19 out of 5 starsMedical Sector1188th out of 1,418 stocksHealth Services Industry12th out of 18 stocksAnalyst Opinion: 3.2Community Rank: 1.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 - 3.2 Analyst's Opinion Consensus RatingBabylon has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.00, Babylon has a forecasted upside of 455.6% from its current price of $1.08.Amount of Analyst CoverageBabylon has only been the subject of 3 research reports in the past 90 days. Previous Next 1.5 Community Rank Outperform VotesBabylon has received 5 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBabylon has received 18 “underperform” votes. (Add your “underperform” vote.)Community SentimentBabylon has received 78.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Babylon and other stocks. Vote “Outperform” if you believe BBLN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BBLN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBabylon does not currently pay a dividend.Dividend GrowthBabylon does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Babylon insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Babylon are expected to grow in the coming year, from ($1.12) to ($1.01) per share.Price to Book Value per Share RatioBabylon has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Babylon (NYSE:BBLN)Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.Read More BBLN Stock News HeadlinesJune 23, 2022 | businesswire.comBabylon Holdings Limited Announces Completion of Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants - Business WireJune 23, 2022 | finance.yahoo.comBabylon Holdings Limited Announces Completion of Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding WarrantsJune 23, 2022 | benzinga.comB of A Securities Initiates Coverage On Babylon Holdings with Neutral Rating, Announces Price Target of $ - BenzingaJune 23, 2022 | benzinga.comHow Babylon, One Of The Fastest-Growing Digital Healthcare Companies In The World, Is Looking To Make Hea - BenzingaJune 22, 2022 | americanbankingnews.comBabylon Holdings Limited (NYSE:BBLN) Receives $7.71 Average PT from BrokeragesJune 21, 2022 | finance.yahoo.comBabylon Holdings Limited Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants - Yahoo FinanceJune 21, 2022 | finance.yahoo.comBabylon Holdings Limited Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its WarrantsJune 13, 2022 | businesswire.comBabylon Set to Join Russell 3000® Index - Business WireJune 13, 2022 | finance.yahoo.comBabylon Set to Join Russell 3000® IndexJune 8, 2022 | americanbankingnews.comBabylon (NYSE:BBLN) Upgraded by Zacks Investment Research to HoldJune 8, 2022 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) & Babylon (NYSE:BBLN) Financial ReviewJune 7, 2022 | finance.yahoo.comBabylon’s ‘Ask The CEO’ Series Continues on June 23June 6, 2022 | seekingalpha.comYumanity, Babylon top healthcare gainers; while Praxis, eFFECTOR lead losers' pack - Seeking AlphaSee More Headlines Industry, Sector and Symbol Stock ExchangeNYSE Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNYSE:BBLN CUSIPN/A CIK1866390 Webwww.babylonhealth.com Phone44 20 7100 0762FaxN/AEmployees2,573Year FoundedN/ACompany Calendar Last Earnings5/12/2022Today6/24/2022Next Earnings (Estimated)8/11/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$6.00 High Stock Price Forecast$10.00 Low Stock Price Forecast$1.50 Forecasted Upside/Downside+455.6%Consensus RatingHold Rating Score (0-4)2.42857142857143 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio3.30 Current Ratio2.20 Quick Ratio2.20 Sales & Book Value Annual Sales$322.92 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$3.83 per share Price / Book0.28Miscellaneous Outstanding Shares43,125,000Free FloatN/AMarket Cap$46.58 million OptionableNot Optionable Beta1.21 Babylon Frequently Asked Questions Should I buy or sell Babylon stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Babylon in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Babylon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BBLN, but not buy additional shares or sell existing shares. View analyst ratings for Babylon or view top-rated stocks. What is Babylon's stock price forecast for 2022? 7 Wall Street analysts have issued 12 month price objectives for Babylon's shares. Their BBLN stock forecasts range from $1.50 to $10.00. On average, they predict Babylon's stock price to reach $6.00 in the next year. This suggests a possible upside of 455.6% from the stock's current price. View analysts' price targets for Babylon or view top-rated stocks among Wall Street analysts. How has Babylon's stock price performed in 2022? Babylon's stock was trading at $5.83 at the beginning of 2022. Since then, BBLN stock has decreased by 81.5% and is now trading at $1.08. View the best growth stocks for 2022 here. Are investors shorting Babylon? Babylon saw a increase in short interest in May. As of May 31st, there was short interest totaling 1,140,000 shares, an increase of 119.9% from the May 15th total of 518,300 shares. Based on an average daily trading volume, of 961,500 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.2% of the company's stock are sold short. View Babylon's Short Interest. When is Babylon's next earnings date? Babylon is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Babylon. How were Babylon's earnings last quarter? Babylon Holdings Limited (NYSE:BBLN) released its quarterly earnings data on Thursday, May, 12th. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.01. The company had revenue of $266.45 million for the quarter, compared to analysts' expectations of $238.49 million. View Babylon's earnings history. What guidance has Babylon issued on next quarter's earnings? Babylon issued an update on its FY 2022 earnings guidance on Thursday, June, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.00B-, compared to the consensus revenue estimate of $966.89 million. Who are Babylon's key executives? Babylon's management team includes the following people: Dr. Ali Parsadoust, Founder, Chairman & CEO (Age 56)Mr. Charlie Steel, Chief Financial Officer (Age 37)Mr. Steve Davis, Chief Technology Officer (Age 55)Ms. Stina Sanders, Communications Mang.Ms. Samira Lowman, Chief People OfficerMr. Darshak Sanghavi M.D., Global Chief Medical Officer (Age 51)Mr. Paul-Henri Ferrand, Chief Bus. Officer (Age 58)Mr. Yon Nuta, Chief Product Officer (Age 41)Ms. Mairi Johnson, Chief Partnerships Officer & Employee Director (Age 55) Who are some of Babylon's key competitors? Some companies that are related to Babylon include P3 Health Partners (PIII), UpHealth (UPH), Covalon Technologies (CVALF), Better Therapeutics (BTTX), Mitesco (MITI), Xcelerate (XCRT), Union Dental (UDHI), Accelera Innovations (ACNV), Advanzeon Solutions (CHCR) and DCC (DCCPF). View all of BBLN's competitors. What is Babylon's stock symbol? Babylon trades on the New York Stock Exchange (NYSE) under the ticker symbol "BBLN." Who are Babylon's major shareholders? Babylon's stock is owned by many different retail and institutional investors. Top institutional investors include Qube Research & Technologies Ltd (0.79%), Nicholas Investment Partners LP (0.23%), Goldman Sachs Group Inc. (0.11%) and Renaissance Technologies LLC (0.10%). Which major investors are buying Babylon stock? BBLN stock was acquired by a variety of institutional investors in the last quarter, including Nicholas Investment Partners LP, Qube Research & Technologies Ltd, Renaissance Technologies LLC, and Goldman Sachs Group Inc.. How do I buy shares of Babylon? Shares of BBLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Babylon's stock price today? One share of BBLN stock can currently be purchased for approximately $1.08. How much money does Babylon make? Babylon (NYSE:BBLN) has a market capitalization of $46.58 million and generates $322.92 million in revenue each year. How many employees does Babylon have? Babylon employs 2,573 workers across the globe. How can I contact Babylon? The official website for Babylon is www.babylonhealth.com. The company can be reached via phone at 44 20 7100 0762 or via email at [email protected]. This page (NYSE:BBLN) was last updated on 6/24/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here